Drug Shortage Report for SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE HD

Last updated on 2025-04-01

Report ID 250519
Drug Identification Number 02470446
Brand name SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE HD
Common or Proper name PERINDOPRIL ERBUMINE/ INDAPAMIDE HD
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) INDAPAMIDE PERINDOPRIL ERBUMINE
Strength(s) 2.5MG 8MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100TAB
ATC code C09BA
ATC description ACE INHIBITORS, COMBINATIONS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2025-02-17
Estimated end date 2025-03-28
Actual end date 2025-03-31
Shortage status Resolved
Updated date 2025-04-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 4600 RUE ARMAND-FRAPPIER
SAINT-HUBERT, QUEBEC
CANADA J3Z 1G5
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2025-04-01 English Compare
v8 2025-03-31 French Compare
v7 2025-03-31 English Compare
v6 2025-03-24 French Compare
v5 2025-03-24 English Compare
v4 2025-03-10 French Compare
v3 2025-03-10 English Compare
v2 2025-02-18 French Compare
v1 2025-02-18 English Compare

Showing 1 to 9 of 9